However, Wnt5a has also been reported to play an opposing tumor-suppressive role by abrogating the YAP/TAZ pathway, as evidenced by its negative feedback in the ROR2-YAP/TAZ pathway in a prostate cancer model [39]. This evidence concerns the gene WNT5A and prostate cancer.